NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity

June 18, 2020

NuVasive, Inc. today announced the expansion of its complex spine portfolio with the global commercial availability of Reline 3D™, a posterior fixation system for patients suffering from pediatric spinal deformities.

NuVasive describes the Reline 3D system as optimized for the treatment of adolescent idiopathic scoliosis (AIS), which involves intricate surgical techniques to address the three-dimensional deformity present in the spine.

The system unifies current deformity techniques involving multi-step, single-plane correction, into one holistic procedure enabling surgeons to overcome current inefficiencies in the operating room. Reline 3D is designed to provide simultaneous, three-dimensional deformity correction, through a simplified procedure, offering surgeons versatility without sacrificing a reproducible surgical experience.

“Prior to Reline 3D, my approach to treating three-dimensional spinal deformities in pediatrics was inefficient and required treating the coronal, sagittal, and axial planes separately,” said Dr. Robert Cho, chief of staff and pediatric orthopedic surgeon at Shriners for Children Medical Center in Pasadena, California. “Reline 3D allows me to simultaneously correct all three planes of the deformity at once, minimizing stress on the bone-screw interface and rod deformation, and maximizing my three-dimensional correction in patients with complex spinal curvatures.”

Reline 3D is an extension of NuVasive’s Reline® system, the most comprehensive fixation portfolio in spine, including Reline Open, Reline MAS, Reline Trauma and Reline Small Stature. Since its commercial launch, NuVasive has continued to invest in the Reline system with increased capabilities and applications spanning from open to minimally invasive surgery, all designed to treat a vast array of spinal pathologies under one portfolio.

“Reline 3D represents a true procedural solution that increases efficiencies and supports a less invasive approach to addressing complex pathologies,” said Matt Link, president of NuVasive. “As an innovative leader in less invasive surgery, NuVasive is committed to providing industry-leading procedures and technologies that enable health systems and surgeons to provide the same standard of care while reducing operative time and length of stay in the hospital. With this launch of Reline 3D, we have expanded this commitment to the AIS patient population.”

Reline 3D is commercially available to patients within the United States and European markets, and is expected to launch in other countries next year.

“As a key pioneer in expanding the utility of NuVasive’s Reline portfolio to create the Reline 3D system, it excites me that this differentiated solution is now widely available to the global spinal deformity community,” said Mr. Stewart Tucker, orthopaedic surgeon at Great Ormond Street Hospital in London, England. “Reline 3D creates a streamlined solution for complex deformities and my peers in the European spinal community have converted to using it simply based on its correctional ability, efficiencies and versatile applications across pediatric and adult spinal deformities.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.